Latest Carcinoma Stories
Study Results Featured in Plenary Session at Society of Gynecologic Oncology Annual Meeting IRVING, Texas, March 30, 2015 /PRNewswire/ -- Caris Life Sciences® today announced the
MELBOURNE, Australia, March 11, 2015 /PRNewswire/ -- Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"), an emerging healthcare company focusing on the development of
Research Presented at 2015 Genitourinary Cancers Symposium Provides Potential Implications for Choice of Therapy and Clinical Trial Participation IRVING, Texas, Feb.
Research Presented at 2015 Gastrointestinal Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence IRVING, Texas, Jan.
Research Presented at 2015 Gastrointestinal Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence in Elucidating Disease Biology and Identifying Potential Treatment Options
DALLAS, December 6, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014" therapeutic market research
PHILADELPHIA, Pennsylvania, October 22, 2014 /PRNewswire/ -- In collaboration with West Cancer Center at University of Tennessee, the comprehensive Center of Excellence
Results, Published in Clinical Genitourinary Cancer, Offer Key Insights and Potential New Treatment Strategies for Patient Population with Limited Drug Options IRVING, Texas, Oct.
CEO to Present Significance of Announced Clinical Trial Results for Lead Drug G-202 Treating Hepatocellular Carcinoma (HCC) Patients to Wall Street Audience SAN ANTONIO, Aug.
New study finds that smartphone teledermoscopy referrals improve triage of cancer patients San Francisco, CA (PRWEB) August 05, 2014 Researchers from